Open house Arzneimittelrabattverträge zum Wirkstoff Golimumab, ATC L04AB06

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse offers all interested pharmaceutical companies, without a selection decision, discount agreements with the above-mentioned active ingredient. Contract awards shall be concluded within the framework of an "Open House model". The agreements offered are not exclusive; agreements with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse. In the Open House model, uniform conditions apply to all participants. Contract content, terms and conditions, and access procedures are uniform—individual negotiations are not carried out. The contract terms are a maximum of 24 months; the earliest possible start date is 01.11.2026. All contracts end no later than 24 months after the day of the earliest contract start date, irrespective of the date of the respective contract award. Accession and/or contract award may take place within the 24-month period each time on the first day of every month. There is a right of termination each time 6 weeks before the end of the month, in accordance with the provisions of the contract. Further information regarding the options for termination is…

TENDER BRIEF

TENDER DOCUMENTS